Skip to content

Study · Measured the body's own peptide · 2023

6 results

Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation.

Amado CA, Martín-Audera P, Agüero J, Ferrer-Pargada D, Josa Laorden B, Boucle D, Berja A, Lavín BA, Guerra AR, Ghadban C, Muñoz P, García-Unzueta M

Chronic respiratory disease1 Jan 2023Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study6

No result from this study comes from a test of the peptide.

Natural levels measured6

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In patients admitted for COPD exacerbation, serum levels of the body's own MOTS‑c were lower than in patients with stable COPD.

    In plain wordsIn people admitted with a COPD flare-up, the body's own MOTS‑c levels were lower than in people with stable COPD.

    Peptide
    MOTS-c
    Outcome
    DecreaseSerum MOTS-c in ECOPD versus stable COPD
    Study

    n = 211

    Comparator
    Stable COPD
    Outcome group
    Mitochondrial function · Respiratory

    Source sentences

    Summary
    Serum FGF-21 (p < .001), MOTS-c (p < .001) and Romo1 (p = .002) levels were lower, and GDF-15 (p < .001) levels were higher, in patients with ECOPD than stable COPD, but no differences were found in HN.
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    Serum MOTS‑c had good diagnostic power for COPD exacerbation (AUC 0.744), similar to C-reactive protein.

    In plain wordsThe body's own MOTS‑c level helped identify COPD flare-ups, with accuracy similar to the standard marker C-reactive protein.

    Peptide
    MOTS-c
    Outcome
    Not applicableDiagnostic accuracy of MOTS-c for ECOPD (ROC AUC)
    Study

    n = 211

    Outcome group
    Mitochondrial function · Respiratory

    Measurements

    AUC
    0.744
    MOTS-c for ECOPD

    Source sentences

    Summary
    In receiver operating characteristic analysis, MOTS-c (AUC 0.744, 95% CI 0.679-0.802, p < .001) and GDF-15 (AUC 0.735, 95% CI 0.670-0.793, p < .001) had the best diagnostic power for ECOPD, with a diagnostic accuracy similar to that of C-RP (AUC 0.796 95% IC 0.735-0.848, p < .001).
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

  3. 03HumanEndogenous levelObservational studyOther

    Serum humanin levels did not differ between patients with COPD exacerbation and patients with stable COPD.

    In plain wordsThe body's own humanin levels were similar in people with a COPD flare-up and in people with stable COPD.

    Peptide
    Humanin
    Outcome
    No significant changeSerum humanin in COPD exacerbation versus stable COPD
    Study

    n = 211

    Comparator
    Stable COPD
    Outcome group
    Mitochondrial function · Respiratory

    Source sentences

    Summary
    but no differences were found in HN.
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

  4. 04HumanEndogenous levelObservational studyOther

    Humanin levels did not differentiate patients with COPD exacerbation from patients with stable COPD.

    In plain wordsThe body's own humanin levels could not tell a COPD flare-up from stable COPD.

    Peptide
    Humanin
    Outcome
    No significant changeHumanin diagnostic power for COPD exacerbation
    Study

    n = 211

    Comparator
    Stable COPD
    Outcome group
    Mitochondrial function · Respiratory

    Source sentences

    Summary
    HN levels did not differentiate patients with ECOPD versus stable COPD (p = .557).
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

  5. 05HumanEndogenous levelObservational studyOther

    In patients admitted for COPD exacerbation, MOTS‑c levels above the mean were an independent risk factor for re-admission (HR 3.441).

    In plain wordsIn people admitted with a COPD flare-up, higher body's own MOTS‑c levels were linked to a higher chance of returning to hospital.

    Peptide
    MOTS-c
    Outcome
    Not applicableMOTS-c level and risk of re-admission
    Study

    n = 51

    Outcome group
    Mitochondrial function · Respiratory

    Measurements

    HR
    3.441
    MOTS-c above mean, re-admission

    Source sentences

    Summary
    In Cox regression analysis, HN (HR 2.661, CI95% 1.009-7.016, p = .048) and MOTS-c (HR 3.441, CI95% 1.252-9.297, p = .016) levels exceeding mean levels were independent risk factors for re-admission.
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

  6. 06HumanEndogenous levelObservational studyOther

    In patients admitted for COPD exacerbation, humanin levels above the mean were an independent risk factor for re-admission.

    In plain wordsIn people admitted for a COPD flare-up, higher natural humanin levels were linked to a higher risk of later re-admission.

    Peptide
    Humanin
    Outcome
    IncreaseHumanin above mean level and re-admission risk
    Study

    n = 51

    Outcome group
    Mitochondrial function · Respiratory

    Measurements

    Hazard ratio
    2.661
    humanin above mean level
    95% CI
    1.009 to 7.016
    hazard ratio for re-admission

    Source sentences

    Summary
    In Cox regression analysis, HN (HR 2.661, CI95% 1.009-7.016, p = .048)
    1 context sentence
    Summary · context
    A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 18Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 15 times, first on 13 Oct 2026, 21:44 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    10 Oct 2026, 08:19 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.